Displaying items by tag: Vaccines

GUEST OPINION: While 2020 and 2021 were marked by COVID-19, 2022 is set to be a year of recovery with organisations settling into new ways of working.

Global end-use of public cloud services is expected to boom this year, with technology analyst firm Gartner predicting a 23.1% rise in spending and reach US$332.3 billion (A$428.7 billion) from US$270 billion in 2020.

COVID-19 provided fertile ground for attackers to sow confusion and take advantage of healthcare organisations on the front lines, according to global cybersecurity company Varonis.

With the world currently undergoing one of the largest and most complex vaccination campaigns in history, it's not surprising to find scammers and sellers on the dark market eager to make a profit off the process.

Alibaba's global research initiative has compiled its must-read forecast of the fascinating leading trends that will shape the tech industry in the year ahead.

Australia’s Communicable Disease Genomics Network (CDGN) and American biotech company Illumina are collaborating to track COVID-19 using next-generation genomic sequencing technology, which enables real-time data sharing and integration to better understand the transmission and spread of the virus.

Australian clinical trials startup HealthMatch has released a global COVID-19 clinical trials tracker to map developments on research breakthroughs around the world.

Sydney-based Bizcaps Software has partnered with Australia’s Authenticateit to use its expertise in healthcare supply chain technology with Authenticateit’s mobile app protection platform in the global fight against counterfeit medicines.

Listed Australia brand protection and customer engagement solutions company,YPB Group, has inked a three-year agreement with Indonesian pharmaceutical and wellness company, Combiphar, for the supply of brand protection solutions in Asia to help in the detection of counterfeit pharmaceuticals and vaccines.